Acute pulmonary exacerbation and lung function decline in patients with cystic fibrosis: high-mobility group box 1 (HMGB1) between inflammation and infection

Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis

Henry J. Fuchs, Drucy Borowitz, David Høyrup Christiansen et al. · New England Journal of Medicine · 1994 · 1.5K citations · Full text

Life Sciences, Biotechnology, Molecular Biology +14

Cutting Edge: HMG-1 as a Mediator of Acute Lung Inflammation

Edward Abraham, John J. Arcaroli, Aaron Carmody et al. · The Journal of Immunology · 2000 · 691 citations · Full text

Veterinary Medicine, Immunology, Pathology +17

Pulmonary function between 6 and 18 years of age

Xiaobin Wang, Douglas W. Dockery, David Wypij et al. · Pediatric Pulmonology · 1993 · 655 citations

Health Professions, Child Health, Pediatrics +17

Microbiology of Sputum from Patients at Cystic Fibrosis Centers in the United States

Jane L. Burns, Julia Emerson, Jenny R. Stapp et al. · Clinical Infectious Diseases · 1998 · 421 citations

Life Sciences, Infectious Diseases, Microbiology +17

Sputum Biomarkers of Inflammation and Lung Function Decline in Children with Cystic Fibrosis

Scott D. Sagel, Brandie D. Wagner, Margaret M. Anthony et al. · American Journal of Respiratory and Critical Care Medicine · 2012 · 247 citations · Full text

Veterinary Medicine, Immunology, Pediatrics +17